Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. . 2012 Jan; 158A(1):24-41.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.